Cargando…
“Is a cure in my sight?” Multi-stakeholder perspectives on phase I choroideremia gene transfer clinical trials
PURPOSE: Ocular gene transfer clinical trials are raising patient hopes for the treatment of choroideremia – a blinding degenerative retinopathy. Phase I choroideremia gene transfer trials necessitate communicating about the risks of harm and potential benefits with patients while avoiding the sensa...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018498/ https://www.ncbi.nlm.nih.gov/pubmed/24071795 http://dx.doi.org/10.1038/gim.2013.148 |